Emad Saleem Alnemri (Arabic: عماد سليم النمري) is a professor in Biochemistry & Molecular Biology at the Sidney Kimmel Cancer Center, Thomas Jefferson University, researching apoptosis and the inflammasome.
Alnemri's group discovered many of the caspases involved in apoptosis.[1] He also discovered that a mutation in the mitochondrial serine protease Omi causes neurodegeneration.[2]
He studied at the University of Jordan on the "Isolation and characterization of goat tear lysozyme" then received his Ph.D. from the Temple University School of Medicine in 1991, where his thesis was on "Molecular Mechanisms of Glucocorticoid-induced Programmed Cell Death in Lymphoid Tissues", under advisor Gerald Litwack. He has held the Thomas Eakins endowed Professorship since 2009. As of 2011, he had an h-index of 77 and 24,523 citations to his 137 articles.[3] He was an ISI Highly Cited Researcher 2001.[4]
References
- ^ "Apoptosis". The Scientist. December 8, 1997. Retrieved May 17, 2015.
- ^ Archibald, Sarah (December 2003). "Mutated mitochondrial serine protease causes neurodegeneration". Lancet Neurology. 2 (12): 717. doi:10.1016/S1474-4422(03)00604-5. S2CID 54400575.
- ^ Boyack, K. W.; Klavans, R.; Sorensen, A. A.; Ioannidis, J. P. A. (2013). "A list of highly influential biomedical researchers, 1996-2011". European Journal of Clinical Investigation. 43 (12): 1339–1365. doi:10.1111/eci.12171. PMID 24134636. S2CID 13259290.
- ^ "Highly Cited Researchers". Thomson Reuters. Retrieved May 17, 2015.
External links
| Authority control databases: Academics |
|---|
   | This article about an American biochemist is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 10 December 2023, at 23:11